X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (36) 36
hematology (29) 29
female (27) 27
male (23) 23
middle aged (21) 21
adult (19) 19
oncology (15) 15
aged (14) 14
index medicus (11) 11
multiple myeloma (9) 9
chemotherapy (8) 8
aged, 80 and over (7) 7
prognosis (7) 7
chronic myeloid leukemia (6) 6
retrospective studies (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
coagulation (5) 5
hemic and lymphatic diseases (5) 5
peripheral vascular disease (5) 5
survival (5) 5
treatment outcome (5) 5
autologous transplantation (4) 4
bone marrow (4) 4
chronic myelogenous leukemia (4) 4
cyclophosphamide - administration & dosage (4) 4
diseases of the blood and blood-forming organs (4) 4
doxorubicin - administration & dosage (4) 4
flow cytometry (4) 4
internal medicine (4) 4
lymphoma (4) 4
myelodysplastic syndrome (4) 4
non-hodgkin lymphoma (4) 4
rituximab (4) 4
young adult (4) 4
acute lymphoblastic leukemia (3) 3
analysis (3) 3
antineoplastic agents - therapeutic use (3) 3
bcr-abl1 (3) 3
blood platelets (3) 3
bortezomib (3) 3
case report (3) 3
classification (3) 3
cml (3) 3
diffuse large b-cell lymphoma (3) 3
disease progression (3) 3
fibrinolysis (3) 3
further section (3) 3
hemik ve lenfatik hastalıklar (3) 3
immunophenotyping (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3) 3
lymphocytes (3) 3
molecular response (3) 3
multiple myeloma - drug therapy (3) 3
nilotinib (3) 3
non-hodgkins-lymphoma (3) 3
patients (3) 3
risk factors (3) 3
stem cells (3) 3
survival rate (3) 3
tafi (3) 3
therapy (3) 3
thromboembolism (3) 3
tumors (3) 3
turkey - epidemiology (3) 3
tyrosine kinase inhibitor (3) 3
activation (2) 2
adolescent (2) 2
age (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
association (2) 2
behcet's disease (2) 2
behçet's disease (2) 2
biomarkers (2) 2
biomarkers - blood (2) 2
biopsy (2) 2
blood (2) 2
bone marrow - pathology (2) 2
breast neoplasms - pathology (2) 2
cancer (2) 2
carboxypeptidase b2 - blood (2) 2
cd56 (2) 2
cd56 antigen - biosynthesis (2) 2
cell lymphoma (2) 2
cmml (2) 2
comorbidity (2) 2
cyclophosphamide (2) 2
cytogenetics (2) 2
deep-vein thrombosis (2) 2
diagnosis (2) 2
disease (2) 2
disease-free survival (2) 2
expression (2) 2
factor-v-leiden (2) 2
fcγriiia (2) 2
follow-up (2) 2
gene (2) 2
hematology, oncology and palliative medicine (2) 2
hematopoietic stem cells (2) 2
identification (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Robak, Tadeusz and Jin, Jie and Pylypenko, Halyna and Verhoef, Gregor and Siritanaratkul, Noppadol and Drach, Johannes and Raderer, Markus and Mayer, Jiri and Pereira, Juliana and Tumyan, Gayane and Okamoto, Rumiko and Nakahara, Susumu and Hu, Peter and Appiani, Carlos and Nemat, Sepideh and Cavalli, Franco and Van Hoof, Achiel and Sheliga, Adriana and Teixeira, Adriana and Tomita, Akihiro and Rocafiguera, Albert Oriol and Suvorov, Alexander and Kuzmin, Alexy and Khojasteh, Ali and Mezlini, Amel and Golenkov, Anatoly and Bosly, Andre and Belch, Andrew and Van De Velde, Ann and Illes, Árpád and Mukhopadhyay, Ashis and Meddeb, Balkis and De Prijck, Bernard and Garichochea, Bernardo and Undar, Bulent and Gabarrón, Caballero and Cao, Carmen and Souza, Carmino and Farber, Charles and Won Suh, Cheol and Burcoveanu, Cristina Ileana and Cebotaru, Cristina Ligia and Truica, Cristina-Ligia and Maruyama, Dai and Belada, David and Ben Yehuda, Dina and Udovitsa, Dmitry and Dolores and Morra, Enrica and Späth-Schwalbe, Ernst and Gonzalez-Barca, Eva and Osmanov, Evgenii and Capote, Francisco Javier and Offner, Fritz and Cardenas, Galvez and Heß, Georg and Manikhas, Georgii and Babu, Govind and Rekhtman, Grigoriy and Rossi, Guiseppe and Marques, Herlander and Marques, Margarida and Bumbea, Horia and Wang, Zhao and Wang, Huaqing and Huang, Huiqiang and Choi, Ilseung and Bulavina, Irina and Lysenko, Irina and Avivi, Irit and Kryachok, Iryna and Zaucha, Jan Maciej and Novak, Jan and Díaz, Joaquín and Demeter, Judit and Alexeeva, Julia and Zhu, Jun and Vilchevskaya, Kateryna and Ishizawa, Kenichi and Mauricio, Kenny and Tobinai, Kensei and Ando, Kiyoshi and Abdulkadryrov, Kudrat and Shih, Lee-Yung and Kuzina, Lyudmila and Gumus, Mahmut and De Wit, Maike and Capra, Marcelo and Golubeva, Marina and Ojeda-Uribe, Mario and Kyselyova, Maryna and Taniwaki, Masafumi and Federico, Massimo and Crump, Michael and Baccarani, Michele and Ogura, Michinori and Egyed, Miklós and Udvardy, Miklos and Kurosawa, Mitsutoshi and Uike, Naokuni and ... and LYM-3002 investigators
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1449 - 1458
In the LYM-3002 study, the efficacy and safety of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) and rituximab,... 
NON-INFERIORITY | TRIAL | 1ST-LINE TREATMENT | IMMUNOCHEMOTHERAPY | MULTICENTER | NETWORK | MANAGEMENT | ONCOLOGY | PLUS RITUXIMAB | GUIDELINES | INDOLENT | Anthracyclines | Cyclophosphamide | Corticosteroids | Bortezomib | Analysis | Prednisone | Steroids
Journal Article
Indian Journal of Hematology and Blood Transfusion, ISSN 0971-4502, 10/2018, Volume 34, Issue 4, pp. 677 - 683
Journal Article
Journal Article
Journal of laboratory physicians, ISSN 0974-2727, 10/2018, Volume 10, Issue 4, pp. 363 - 369
Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of... 
Studies | Blood platelets | Cytokines | Lymphocytes | Medical prognosis | Neutrophils | Multiple myeloma | Bone marrow | Multivariate analysis | Growth factors | platelet-to-lymphocyte ratio | neutrophil-to-lymphocyte ratio | new prognostic marker | Original
Journal Article
Journal Article
Hematology, ISSN 1024-5332, 03/2018, pp. 1 - 7
Nilotinib is a BCR-ABL1 tyrosine kinase inhibitor approved for the treatment of patients with chronic myeloid leukemia in chronic phase (CML-CP). This study... 
chronic myeloid leukemia | molecular response | tyrosine kinase inhibitor | nilotinib | BCR-ABL1
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 5532 - 5532
Abstract Introduction Nilotinib, a more potent and selective BCR-ABL-1 inhibitor than imatinib, is approved by the FDA and EMA 1) for the treatment of chronic... 
Journal Article
Clinical Lymphoma, Myeloma & Leukemia, ISSN 2152-2650, 2015, Volume 15, Issue 6, pp. e101 - e104
Journal Article
Hematology, ISSN 1024-5332, 11/2018, Volume 23, Issue 10, pp. 771 - 777
Objectives: This report presents final results (24 months of follow-up) from the first prospective, national study of frontline nilotinib in chronic myeloid... 
chronic myeloid leukemia | molecular response | tyrosine kinase inhibitor | nilotinib | BCR-ABL1 | TREATMENT-FREE REMISSION | INTERFERON | DIAGNOSED CHRONIC-PHASE | IMATINIB | CYTARABINE | OUTCOMES | HEMATOLOGY | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 2742 - 2742
Abstract Introduction Nilotinib, a more potent and selective drug than imatinib, was approved by the FDA and EMA initially for the treatment of chronic and... 
Journal Article
TURKISH JOURNAL OF HEMATOLOGY, ISSN 1300-7777, 12/2018, Volume 35, Issue 4, pp. 271 - 276
Journal Article
TURKISH JOURNAL OF HEMATOLOGY, ISSN 1300-7777, 2019, Volume 36, Issue 2, pp. 81 - 87
Objective: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). The treatment of older NHL patients has always been a... 
SUBTYPE | CLASSIFICATION | DES LYMPHOMES | CHOP CHEMOTHERAPY | GERIATRIC ONCOLOGY | B-Cell neoplasms | Lymphoid cell neoplasms | Non-Hodgkin lymphoma | TRIAL | IMPACT | RITUXIMAB | NON-HODGKINS-LYMPHOMA | Lymphomas | HEMATOLOGY | Studies | Chemotherapy | Hematology | Comorbidity | Biopsy | Medical prognosis | Patients | Cancer therapies | Age | Tumors
Journal Article
Brazilian Journal of Infectious Diseases, ISSN 1413-8670, 06/2009, Volume 13, Issue 3, pp. 238 - 241
A patient with mantle cell non-Hodgkin's lymphoma presented herself with fever, nausea, right upper quadrant pain on the 7th day of R-CHOP chemotherapy. After... 
Mucormycosis | Autopsy | Lymphoma | INFECTIOUS DISEASES | ZYGOMYCOSIS | lymphoma | MALIGNANCIES | INFECTION | LEUKEMIA | autopsy | Lymphoma, Mantle-Cell - complications | Humans | Middle Aged | Fatal Outcome | Lymphoma, Mantle-Cell - pathology | Mucormycosis - pathology | Female | Mucormycosis - complications
Journal Article
Acta Obstetricia et Gynecologica Scandinavica, ISSN 0001-6349, 09/2000, Volume 79, Issue 9, pp. 803 - 804
Journal Article